Publications by authors named "Martin Goerner"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

14

Total Likes

0

Extended Reach

953

Social Features

2
R
Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy.
Peter Goon, Odile Sauzet, Matthias Schuermann, Felix Oppel, SenYao Shao, Lars-Uwe Scholtz, Holger Sudhoff, Martin Goerner

NPJ Vaccines· April 2023

Videos about Article: user

1 1 3

View All Article and Social Media Activity
S
Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial.
Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S Raab, Sandra Sauer, Martin Goerner

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib in p.G12C-Mutated Pulmonary Sarcomatoid Carcinoma: Therapeutic Efficacy of a Inhibitor in Symptomatic Brain Metastases.
Jonas Frederik Schmidt, Dominik Entz, Frank Brasch, Martin Goerner

Case Rep Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hit and run oncogeneses in head and neck cancers requires greater investigation.
Peter Goon, Holger Sudhoff, Martin Goerner

J Med Virol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral and Clinical Oncology of Head and Neck Cancers.
Peter Goon, Matthias Schürmann, Felix Oppel, SenYao Shao, Simon Schleyer

Curr Oncol Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Elias K Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Martin Goerner

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.
Eva-Maria Klein, Diana Tichy, Hans J Salwender, Elias K Mai, Jan Duerig, Martin Goerner

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE.
Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Martin Goerner

Leukemia· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Elias K Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Martin Goerner

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Marc-Andrea Baertsch, Elias K Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Martin Goerner

Blood Cancer J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial.
Hartmut Goldschmidt, Elias K Mai, Jan Dürig, Christof Scheid, Katja C Weisel, Martin Goerner

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.
Marc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, Julia Krzykalla, Natalia Becker, Martin Goerner

Eur J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.
Marc-Andrea Baertsch, Jana Schlenzka, Elias K Mai, Maximilian Merz, Jens Hillengaß, Martin Goerner

BMC Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeted therapies in head and neck cancer--an update of recent developments-.
Martin Goerner, Tanguy Y Seiwert, Holger Sudhoff

Head Neck Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancer.
Martin Goerner, Petra Riemer-Hommel

Onkologie· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Painful spinal cord compression as a complication of extramedullary hematopoiesis associated with beta-thalassemia intermedia.
Martin Goerner, Sabine Gerull, Erhard Schaefer, Marianne Just, Martin Sure

Strahlenther Onkol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
Svetlana Karakhanova, Markus Munder, Markus Schneider, Mark Bonyhadi, Anthony D Ho, Martin Goerner

J Immunother· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals.
Thomas Luft, Elena Rodionova, Eugene Maraskovsky, Michael Kirsch, Michael Hess, Martin Goerner

Blood· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Jörg D Seebach, Georg Stussi, Jakob R Passweg, Fausto R Loberiza, James L Gajewski, Martin Goerner

Biol Blood Marrow Transplant· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.
Jacques-Olivier Bay, Nathalie Dhédin, Martin Goerner, Jean-Pierre Vannier, Aude Marie-Cardine

Transplantation· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.
Markus Munder, Faustino Mollinedo, Jero Calafat, Javier Canchado, Cristina Gil-Lamaignere, Martin Goerner

Blood· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs.
Bobbie Thomasson, Laura Peterson, Jesse Thompson, Martin Goerner, Hans-Peter Kiem

Hum Gene Ther· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Martin Goerner, Renate Weber-Nordt, Sabine Hoepfner, Axel Benner, Thomas Luft

J Hematother Stem Cell Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unrelated donor transplantation after reduced intensity conditioning as an approach for patients lacking related donors for allogeneic stem cell transplantation.
Sabine Hoepfner, Martin Goerner, Axel Benner, Peter Henning, Anthony D Ho

J Hematother Stem Cell Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
Stefan Fruehauf, Julian Topaly, Eike C Buss, Moritz Schad, Martin Goerner

Haematologica· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis